ORMP
Price
$2.15
Change
-$0.05 (-2.27%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
87.83M
55 days until earnings call
VALN
Price
$7.00
Change
+$0.09 (+1.30%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
562.18M
34 days until earnings call
Ad is loading...

ORMP vs VALN

Header iconORMP vs VALN Comparison
Open Charts ORMP vs VALNBanner chart's image
Oramed Pharmaceuticals
Price$2.15
Change-$0.05 (-2.27%)
Volume$323
Capitalization87.83M
Valneva SE
Price$7.00
Change+$0.09 (+1.30%)
Volume$988
Capitalization562.18M
ORMP vs VALN Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. VALN commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and VALN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ORMP: $2.20 vs. VALN: $6.92)
Brand notoriety: ORMP and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 22% vs. VALN: 37%
Market capitalization -- ORMP: $87.83M vs. VALN: $566.58M
ORMP [@Biotechnology] is valued at $87.83M. VALN’s [@Biotechnology] market capitalization is $566.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, VALN is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while VALN’s TA Score has 4 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 7 bearish.
  • VALN’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, VALN is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -6.78% price change this week, while VALN (@Biotechnology) price change was -3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

ORMP is expected to report earnings on May 28, 2025.

VALN is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($562M) has a higher market cap than ORMP($87.8M). VALN YTD gains are higher at: 58.271 vs. ORMP (-9.091). VALN has higher annual earnings (EBITDA): 21.2M vs. ORMP (9.44M). VALN has more cash in the bank: 156M vs. ORMP (142M). ORMP has less debt than VALN: ORMP (429K) vs VALN (201M). VALN has higher revenues than ORMP: VALN (159M) vs ORMP (0).
ORMPVALNORMP / VALN
Capitalization87.8M562M16%
EBITDA9.44M21.2M45%
Gain YTD-9.09158.271-16%
P/E Ratio20.91N/A-
Revenue0159M-
Total Cash142M156M91%
Total Debt429K201M0%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPVALN
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 28 days ago
82%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFDKX87.75N/A
N/A
Fidelity K
GAGVX20.89N/A
N/A
Goldman Sachs U.S. Equity ESG A
TDFCX7.91N/A
N/A
Transamerica Sustainable Equity Inc C
LOGWX24.70N/A
N/A
Lord Abbett Developing Growth F3
ANPRX28.47N/A
N/A
Virtus NFJ Mid-Cap Value R6